Association of early dapagliflozin initiation with subclinical changes in cardiac function during anticancer therapy
Early dapagliflozin initiation during anthracycline–trastuzumab therapy was associated with better preservation of LV mechanics and LA remodeling over 12 months, and remained within the normal range in both groups throughout follow-up.